20-F: ECARX inks up to $150M convertible notes deal

Sentiment:

Securities Purchase Agreement


ECARX entered a Securities Purchase Agreement on Oct. 30, 2025 to issue up to $150 million of senior convertible notes, including an initial $50 million tranche, at a 3% original issue discount and a $2.59 initial conversion price.

Capital raiseUp to $150,000,000 senior unsecured convertible notes under SPA dated Oct. 30, 2025; $50,000,000 issued initially; up to $100,000,000 available via buyer‑elected additional closings within 12 and 18 months.3% original issue discount (sold at $970 per $1,000 principal); initial conversion price $2.59 per share; no regular coupon; 12‑month maturity.Monthly amortization payable in cash (107% of principal plus accrued amounts) or shares valued by a VWAP‑based formula (subject to a floor price).Redemption premiums: 25% upon event of default; 20% upon change of control; default interest 14% p.a.Covenants: $25,000,000 minimum cash; share reserve at 100% of max shares at floor price; limits on variable rate financing (except permitted ATM and deSPAC CB refinancing); participation right for future convertible indebtedness.Underlying shares registered under an effective F‑3 and to remain listed on Nasdaq; trustee is U.S. Bank Trust Company, N.A.; placement agent: D. Boral Capital, LLC.

Summary

  • Entered a registered direct Securities Purchase Agreement dated Oct. 30, 2025 with ATW Mobility SPV LLC to issue senior unsecured convertible notes of up to $150,000,000 under effective F-3 shelf (No. 333-288811).
  • Initial issuance: $50,000,000 principal (Initial Notes) at $970 per $1,000 principal (3% OID); additional closings up to $100,000,000 at buyer’s election in two tranches within 12 and 18 months of the Initial Closing, minimum $20,000,000 per additional draw (unless mutually agreed).
  • Notes rank pari passu with other unsubordinated unsecured obligations; issued under an Indenture with U.S. Bank Trust Company, N.A. as trustee (TIA qualified), with Supplemental Indentures for each series.
  • Initial conversion price set at $2.59 per share (subject to standard anti‑dilution); monthly amortization with option to settle in cash (at 107% of principal) or Class A shares valued per a formula tied to recent VWAPs (subject to a floor price mechanism described in the notes).
  • Maturity: 12 months from issuance (per 20‑F), unless earlier converted or redeemed; no cash coupon unless an event of default (then 14% p.a.).
  • Redemptions/premiums: 25% premium on event of default redemption; 20% premium on change of control; company option to mandate conversion if price ≥ $3.88 for 15 consecutive trading days and daily dollar volume > $3,000,000.
  • Proceeds to be used as described in the related Prospectus Supplement; underlying shares listed on Nasdaq Global Market.
  • Covenants include: minimum cash balance of $25,000,000; restrictions on variable rate transactions (with limited exceptions); required share reserve equal to 100% of the maximum shares issuable at the floor price; participation right for certain future convertible indebtedness; leak‑out and no net short provisions.
  • Press release and Form 6‑K disclosure required within one business day of signing; additional disclosure required upon any additional closing notices.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a balanced outcome: the facility shores up liquidity and flexibility, but the short tenor, amortization mechanics, and potential dilution offset positives, leaving a neutral risk‑reward.

Positives

  • Secures near‑term liquidity with up to $150,000,000 of funding flexibility via initial and additional closings under an already‑effective shelf.
  • No stated cash coupon; interest only accrues upon default at 14%, potentially lowering cash interest burden versus traditional converts.
  • Company option to satisfy monthly amortization in shares, preserving cash, and optional mandatory conversion if trading/volume conditions are met (≥ $3.88 for 15 trading days; > $3,000,000 daily volume).
  • Notes are pari passu unsecured obligations, avoiding structural subordination to new secured debt.
  • Participation rights and limitations on variable rate financings (except permitted ATMs and deSPAC CB refinancing) may help limit further highly dilutive financings.

Negatives

  • Material potential dilution from initial conversion price of $2.59 per share and share‑settled amortization mechanics.
  • Short, 12‑month tenor increases refinancing risk if equity price/market conditions are unfavorable at maturity.
  • Change of control (20%) and event‑of‑default (25%) redemption premiums, plus 7% amortization premium in cash settlements, increase effective cost of capital.
  • Covenants (e.g., $25,000,000 minimum cash, share reserve requirements) could constrain financial flexibility.
  • Buyer hedging/trading is permitted (subject to certain limits), which could pressure the share price during measurement periods.

Risks

  • Event of default triggers 14% default interest and a 25% redemption premium, creating significant cash/liquidity stress in a downside scenario.
  • Mandatory minimum cash balance of $25,000,000 must be maintained; breach could cause default.
  • Listing/trading suspension or delisting constitutes an event of default; underlying shares must remain listed on an eligible market (Nasdaq).
  • Required Reserve Amount covenant obligates the company to reserve 100% of the maximum shares issuable upon conversion at the floor price, risking additional shareholder dilution if share authorization must be increased.
  • Restrictions on variable rate transactions limit certain future financing options; exceptions are narrow (permitted ATM and specified deSPAC CB refinancing).
  • Monthly amortization may necessitate regular share issuance if cash is not used, potentially increasing market overhang.

Future Outlook

Management may seek up to $100 million in additional closings within 18 months of the initial issuance, subject to conditions, and can satisfy monthly note amortizations in cash or shares. The company must maintain Nasdaq listing, reserve sufficient shares for conversion at the floor price, and comply with minimum cash and financing covenants.

Management Comments

  • Intends to use proceeds as described in the Prospectus Supplement tied to the registered offering.
  • Affirms eligibility to issue securities under an effective Form F-3 shelf and that conversion shares will be listed on Nasdaq, subject to official notice of issuance.
  • Commits to timely public disclosure of the transaction and any subsequent additional closing notices.

Industry Context

StockSavvy.ai notes that auto-tech and EV ecosystem companies frequently employ convertible note structures to balance liquidity needs against dilution risk. Compared to multi‑year converts often seen at peers, ECARX’s 12‑month tenor is shorter, improving near‑term flexibility but heightening refinancing risk if market conditions weaken. Investor hedging provisions, standard in converts, can pressure share prices during conversion periods across the sector.

Comparison to Industry Standards

  • Relative to typical 3–5 year convertible notes at auto/tech peers (e.g., NIO, XPeng, Luminar) often with 0–3% coupons and 20–35% conversion premiums, ECARX’s 12‑month no‑coupon structure trades duration for speed and flexibility but requires faster refinancing.
  • The 3% OID is modest versus many recent converts with higher effective costs via coupons, step‑ups, or redemption features; however, monthly amortization and 7% cash premium elevate the economic cost versus straight converts.
  • The minimum cash covenant ($25M) and restrictions on variable rate transactions are stricter than many peer converts, potentially providing shareholder protection from excessive dilution but reducing financing optionality.
  • The mandatory conversion trigger ($3.88 price/volume test) is broadly in line with market practice to limit overhang when trading liquidity and price performance are strong.

Stakeholder Impact

  • Shareholders: Potential dilution from conversions and share‑settled amortizations; reduced risk of near‑term liquidity shortfall.
  • Creditors: New pari passu unsecured debt adds to leverage; covenants (minimum cash, variable rate limits) provide some discipline.
  • Employees: Improved liquidity may support operations and R&D continuity.
  • Customers/Suppliers: Greater funding visibility supports delivery commitments and supplier payments.

Next Steps

  • File and maintain effectiveness of the Prospectus Supplement and Form 6‑K disclosures; issue required press releases after signing and any additional closing notices.
  • Satisfy monthly amortization obligations in cash or shares per the note terms; maintain Nasdaq listing and required share reserves.
  • Preserve minimum cash of $25,000,000 and comply with financing covenants, including restrictions on variable rate transactions.
  • Potentially access up to $100,000,000 in additional closings within 12 and 18 months of the Initial Closing, subject to conditions.

Key Dates

DateDescription
2025-10-30Securities Purchase Agreement signing date; initial notes of $50,000,000 issued
2025-10-31Deadline to issue press release and file Form 6‑K disclosing the transaction (first business day after signing)
2026-10-30Maturity of the 2025 ATW Convertible Notes (12 months from issuance), unless earlier converted or redeemed
2026-11-06First Tranche Additional Closing Expiration Date: 5th trading day after first anniversary of Initial Closing (buyer option up to allocated maximum)
2027-04-30Second Tranche Additional Closing Expiration Date: 5th trading day after 18‑month anniversary of Initial Closing (buyer option up to allocated maximum)

Recommendation

hold

Funding improves liquidity and operational runway, but short maturity, potential dilution, and restrictive covenants temper upside. Maintain a hold pending execution on additional closings, share issuance management, and operating progress relative to covenant thresholds.

Keywords

convertible notes, ATW Mobility, ECARX, securities purchase agreement, indenture, Nasdaq, registered direct offering, original issue discount, conversion price, redemption premium, minimum cash covenant, variable rate restriction, deSPAC refinancing, Trust Indenture Act, U.S. Bank Trust Company

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.